Dr. Cush
Rheumnow Podcast
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Future Big BiTEs (6.28.2024) 28.06.2024 18:12
Dr. Jack Cush reviews the news, journal articles and regulatory announcements from the past week on RheumNow.com
EULAR 2024 RA Topic Panel 24.06.2024 45:12
Moderated by Dr. Jack Cush and featuring Drs. Aurelie Najm, David Liew and Jonathan Kay
EULAR 2024 SLE Topic Panel 24.06.2024 46:42
Featuring Drs. Jack Cush, Yuz Yusof, and Andrea Fava
EULAR 2024 Psoriatic Arthritis Topic Panel 24.06.2024 43:17
Moderated by Dr. Jack Cush and Featuring Drs. Eric Ruderman, Antoni Chan, and Peter Nash
EULAR 2024 Rheumatology Roundup 21.06.2024 55:32
Featuring Drs. Artie Kavanaugh and Jack Cush Discussion of highlights from the EULAR 2024 Meeting in Vienna
EULAR 2024 JAK/TYK Daily Topic Podcasts 18.06.2024 32:26
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis? Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib Giant Cell Arteritis an...
EULAR 2024 SpA Daily Topic Podcasts 18.06.2024 40:16
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis? Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib Do MRI changes at the S...
EULAR 2024 SLE Daily Topic Podcasts 18.06.2024 43:38
Does B Cell Depletion Matter? Drs. Yuz Yusof and Ed Vital discuss abstract OP0077 at Eular 2024 in Vienna, Austria. 3 Big Lupus Themes from EULAR 2024 Dr. Janet Pope discusses three hot topics in lupus at Eular 2024 in Vienna, Austria. POS0732 OP0255 Voclosporin and Steroids in Lupus Nephritis Dr. Jack Cush reports on abstract OP0059 presented at Eular 2024 in Vienna, Austria. JAK Inhibitors for...
EULAR 2024 PsA Daily Topic Podcasts 18.06.2024 36:22
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis? Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib JAK Inhibitors for New...
EULAR 2024 RA Daily Topic Podcasts 18.06.2024 1:12:51
Mechanistic Promise in RA Doesn’t Always Mean Actual Gain Dr. David Liew reports on abstracts OP0007 and OP0069 at Eular 2024 in Vienna, Austria. The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis Dr. Mrinalini Dey reports from Eular 2024 in Vienna, Austria about an abstract she will present during the meeting, POS0309. A Step Closer to Identifying Phenotypes of RA ILD...
EULAR Daily Podcasts Day 4 17.06.2024 37:53
Axial & Psoriatic Disease Dr. Peter Nash at Eular 2024 in Vienna, Austria. Difficult to Treat Psoriatic Arthritis Dr. Peter Nash reports at Eular 2024 in Vienna, Austria. Predictors of Treatment Response in Psoriatic Arthritis Dr. Janet Pope reviews three abstracts presented at Eular 2024 in Vienna, Austria. Abstracts discussed: POS 0990 POS 0992 POS 0266 Prevention of Psoriatic Arthritis Dr....
Predictors of Treatment Response in Psoriatic Arthritis 17.06.2024 4:49
Dr. Janet Pope reviews three abstracts presented at Eular 2024 in Vienna, Austria. Abstracts discussed: POS 0990 POS 0992 POS 0266
EULAR 2024 Day 4 Recap 17.06.2024 34:47
Moderated by Dr. Jack Cush and featuring Dr. Aurelie Najm and Dr. David Liew Recorded June 15, 2024
Early Diagnosis of Axial Spondyloarthritis 17.06.2024 5:12
Dr. Antoni Chan reports on abstract OP0310 presented at Eular 2024 in Vienna, Austria.
Imaging in Axial Spondyloarthritis 17.06.2024 6:45
Dr. Antoni Chan reviews abstracts OP0222 and OP0303 presented at Eular 2024 in Vienna, Austria.
EULAR Daily Recap: Day 3 17.06.2024 42:09
EULAR 2024 RECAP DAY 3 Moderated by Dr. Jack Cush with Drs. Bella Mehta and Antoni Chan.
Drug-resistant RA Does Blinatumomab BiTE? 17.06.2024 6:06
Dr. Yuz Yusof reports on abstract OP0193, presented at Eular 2024 in Vienna, Austria.
EULAR Daily Recap: Day 3 17.06.2024 42:09
EULAR 2024 RECAP DAY 3 Moderated by Dr. Jack Cush with Drs. Bella Mehta and Antoni Chan.
EULAR Daily Recap Day 3 17.06.2024 42:09
EULAR 2024 RECAP DAY 3 Moderated by Dr. Jack Cush with Drs. Bella Mehta and Antoni Chan.
Axial & Psoriatic Disease 17.06.2024 2:08
Dr. Peter Nash at Eular 2024 in Vienna, Austria.
Difficult to Treat Psoriatic Arthritis 17.06.2024 3:18
Dr. Peter Nash reports at Eular 2024 in Vienna, Austria.
Prevention of Psoriatic Arthritis 16.06.2024 2:16
Dr. Peter Nash sharing his perspectives on preventing psoriasis from turning into PsA at Eular 2024 in Vienna, Austria.
Digital Rheumatology 16.06.2024 4:23
Dr. Jonathan Kay reviews abstracts POS0451 and POS0607 presented at Eular 2024 in Vienna, Austria.
Depression and Anxiety Associated with Inability to Achieve Remission in RA and PsA 16.06.2024 2:51
Dr. Aurelie Najm reports on abstract POS0946 presented at Eular 2024 in Vienna, Austria.
EULAR 2024 Daily Podcasts Day 3 15.06.2024 1:25:32
Select your GCA Therapy Dr. David Liew discusses LBA0001 presented at Eular 2024 in Vienna, Austria. DMARDs and Herpes Zoster Vaccination: To Stop or Not To Stop Dr. Jonathan Kay discusses abstracts POS0620 and OP0020 presented at Eular 2024 in Vienna, Austria. Has JAK POT Hit the Spot About Infection Risk? Dr. Yuz Yusof discusses abstract OP0092 presented at Eular 2024 in Vienna, Austria. Depress...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.